NCT00686075 · Interventional trial
A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants
Overall registry status Completed
Phase 1 · Phase 2
Conditions Healthy
Delaware Valley sites
- Research Site · Sellersville, PA · Bucks County
First posted
Registry updated
Added to the directory